Chromacode Announces Strategic Investment To Advance Development And Application Of Hdpcr Platform Technology For Use In Oncology Genomics
Round Type
Corporate Round
CarlsbadBiotechnologyHealthcareInvestors
Description
ChromaCode, a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, today announced a strategic investment from corporate venture capital fund Shimadzu Future Innovation Fund L.P., with general partner Global Brain Corporation. This funding will support ChromaCode's continued development of its HDPCR technology to deliver high quality, faster, less expensive diagnostic tools that address unmet clinical needs in disease detection and monitoring.
Quick answer
ChromaCode raised an undisclosed amount in a Corporate Round round, dated June 7, 2023. Investors: Global Brain Corporation and Shimadzu Future Innovation Fund L.P. ChromaCode is based in Carlsbad, California, United States.
- How much did ChromaCode raise?
- ChromaCode raised an undisclosed amount in a Corporate Round round on June 7, 2023.
- Who invested in ChromaCode?
- Global Brain Corporation and Shimadzu Future Innovation Fund L.P. are named as investors in this round.
- What does ChromaCode do?
- ChromaCode is a molecular diagnostics company with a bioinformatics focus and pedigree from Illumina, Google[x], Luminex, and Caltech.
- Where is ChromaCode based and how big is it?
- ChromaCode is based in Carlsbad, California, United States.
- Who are the decision-makers at ChromaCode?
- Fundz holds 1 contact at ChromaCode, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as ChromaCode that raised within 45 days of this round, from Fundz verified event records.
- RedHill Biopharma Ltd raised $2.7M (Seed) on July 21, 2023.
- Propanc Biopharma raised $45K (Seed) on July 19, 2023.
- Streamex Corp. raised $495K (Seed) on July 19, 2023.
- Renibus Therapeutics raised $47M (Funding Round) on July 18, 2023.
- Talphera, Inc. raised $10M on July 17, 2023.
- Endolytix Technology raised $4.3M (Seed) on July 14, 2023.
Who to call at ChromaCode, and when
A new round usually means ChromaCode is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ChromaCode raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ChromaCode, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ChromaCode. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ChromaCode raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ChromaCode raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.